Giloy stem vs leaf, and the species question that matters more

“Giloy” on a label can mean three materially different things: the stem, the leaf, or, and this is the part that matters most, a different species altogether.

The classical texts use the stem. The leaf is cheaper and more abundant. And Tinospora crispa, a confusable relative, has documented hepatotoxicity.

So the stem-versus-leaf question is worth answering, and the species question is worth answering first.

This is a sourcing article. We make giloy products and identity is the single control we care most about.

This is information, not medical advice. Do not take giloy with liver disease, and stop for yellowing of the eyes or dark urine. Our liver article covers this in full.

The species question, and why it comes first

The three species in play

Tinospora cordifolia, giloy, guduchi, amrita. This is the classical plant and the one with the research behind it.

Tinospora crispa, used in parts of Southeast Asia, where it has its own traditional applications. And it has documented hepatotoxicity, with case reports of liver injury associated with its use.

Tinospora sinensis, another relative, sometimes substituted, less studied.

Why this matters enormously

Because the liver injury case reports attributed to giloy in India during 2020–21 generated a specific counter-argument: that at least some of the implicated material may not have been T. cordifolia at all.

That argument is genuinely important and it cuts both ways.

If true for some cases, it partly exonerates the classical species, and shifts the problem from the plant to the supply chain.

And either way, it makes identity testing essential rather than optional, because a buyer cannot tell by looking, and neither can most sellers.

So whatever you conclude about the liver debate, the practical response is the same: confirm the species.

How the plants differ

Visually, to someone who knows what to look for:

T. cordifolia, smooth, heart-shaped leaves with entire (untoothed) margins; stem with small warty protuberances; and thin, thread-like aerial roots hanging down, which is distinctive.

T. crispa, the stem is notably more warty and distinctly ridged or “crisped”, which is where the species name comes from.

And in dried, cut, or powdered form, visual identification becomes unreliable, which is exactly the form in which most material changes hands.

So how identity should be established

And this is the question to put to a supplier.

Macroscopic and microscopic examination, the baseline, and useful on whole or cut material.

HPTLC fingerprinting, a chromatographic profile compared against a reference.

DNA barcoding, the most definitive for species identity, and increasingly used for exactly this problem.

And the practical test of a supplier: ask which of these they do, and ask for the result for your batch. A supplier who says “it is giloy” and cannot say how they know is the risk this whole article is about.

Now: stem or leaf

What the classical texts use

The stem. Specifically the mature stem, and in classical pharmacy the preference is often for a stem of a certain thickness from a mature vine.

Guduchi satva, the starchy extract, is made from the stem, by crushing it in water and allowing the starch to settle.

And Amritarishta and the classical decoctions specify stem.

The leaf has traditional uses too, including topically, and it is not the part the main classical internal preparations are built on.

The chemistry differs

And this is the substantive point rather than a traditionalist one.

Reported differences between stem and leaf include:

Alkaloid content, berberine, palmatine and magnoflorine distribute differently between the parts.

Starch and polysaccharide content, the stem is starch-rich, which is why satva can be made from it at all. The leaf is not.

Glycoside profile, tinocordiside and related compounds vary by part.

And bitter principle intensity.

So the stem and the leaf are not the same material at a different price. They are different chemical mixtures.

And the honest qualifier: the comparative research on stem versus leaf activity is limited. There are studies reporting activity in both, and no good body of work establishing that one is clinically better than the other. What we can say is that the classical preparations use the stem and the modern research has mostly used the stem, which is the same argument we made about ashwagandha root versus leaf.

Why leaf shows up anyway

Three commercial reasons, and they are worth knowing.

Leaf is more abundant. A vine produces leaves continuously; harvesting mature stem is slower and the plant takes longer to recover.

Leaf is cheaper to collect and process.

And whole-plant or aerial-part material is easier to source in bulk than specified mature stem.

So “giloy (whole plant)” or “aerial parts” on a label usually means stem plus leaf, in unstated proportion. That is not fraud if declared. It is a different product from stem extract.

Side by side

	Stem	Leaf	Whole / aerial parts
Classical use	Yes, the main part	Secondary, some topical	Not specified classically
Used in the research	Mostly	Some	Variable
Starch content	High, allows satva	Low	Mixed
Alkaloid profile	Distinct	Distinct, different	Blended, unstated
Cost	Higher	Lower	Lowest
Availability	Slower to harvest	Abundant	Abundant
What a label says	“Stem” / “kanda”	Rarely stated as leaf	“Whole plant”, “aerial parts”

Note the bottom row. Products made from leaf are rarely labelled as leaf. They are labelled “whole plant” or simply “giloy”, and that is the gap a buyer has to close by asking.

What to specify, and what to ask

For anyone sourcing or specifying.

1. Species, and how it was confirmed. Tinospora cordifolia, with the identification method stated. DNA barcoding where the stakes justify it.

2. Plant part, stated explicitly. “Stem”, not “whole plant”, not “aerial parts”, not silence.

3. Maturity, mature stem rather than young growth, where the supplier can specify it.

4. Marker compound assay. Is there a stated figure for a named marker, and by what method? “Giloy extract” with no assay is a commodity, not a specification.

5. Extract ratio and what makes up the rest of the weight, many extracts sit on a maltodextrin carrier.

6. Batch-wise heavy metals, lead, mercury, arsenic, cadmium. Giloy is a climbing vine and takes up what is in its environment.

7. Pesticide residues and microbiology.

8. And for liquid products: diethylene and ethylene glycol testing on every solvent batch. Children in India have died from contaminated syrups.

9. And the host tree, if the supplier claims neem giloy. The classical preference for giloy grown on neem is traditional and there is no modern evidence for it, so if a product charges a premium for it, that premium is buying tradition, not data. We think that should be said plainly rather than implied.

And the sustainability point

Worth raising because it affects supply and therefore adulteration.

Demand for giloy rose sharply in 2020–21, and sharp demand spikes in wild-collected botanicals are exactly when adulteration and substitution increase, because legitimate supply cannot expand fast enough.

Which means the period that generated the liver case reports was also the period of maximum supply-chain pressure. Those two facts are related, and that is part of why the identity argument is credible.

And it argues for cultivated rather than wild-collected material, where a supplier can offer it, for traceability as much as for conservation.

Claims, unchanged by plant part

What is sayable: a traditional-use statement for giloy, framed clearly as traditional use, plus authorised nutrient-function claims for any vitamins and minerals present.

And there is no authorised health claim for giloy, stem, leaf or otherwise.

What is not sayable: boosts immunity, treats fever, helps in dengue, raises platelets, prevents infection, or protects the liver.

And a specific one for this article: “classical stem extract” is a factual sourcing statement when true, and it cannot be used to imply an efficacy the label may not claim. Describing the material accurately is not a route to claiming a benefit.

What we do

We specify Tinospora cordifolia, stem, with identity confirmation, and we state the plant part on the label.

We require batch-wise heavy metal and identity certificates, and we do not accept “whole plant” material for products sold as giloy stem.

And we print a maximum duration statement and a liver-symptom warning, which our liver and duration articles explain.

What we decline: “whole plant” material sold as classical giloy; any dengue or platelet claim; and “hepatoprotective” on a giloy pack.

And the honest commercial note: stem-only material with DNA-confirmed identity costs meaningfully more than commodity giloy powder. That difference is invisible on a shelf, which is the structural problem in this category, and the only thing that fixes it is stating the plant part and the identity method on the label, so the difference becomes visible.

When to see a doctor

Stop and seek advice urgently:

• Yellowing of the eyes or skin, dark urine, pale stools, persistent nausea, or right upper abdominal pain

Before starting giloy in any form:

• Any liver disease, including fatty liver, hepatitis B or C, or past drug-induced liver injury
• Any autoimmune condition, or on immunosuppressants
• Diabetes medication, it lowers glucose; monitor
• Pregnancy or breastfeeding, avoid
• Before surgery
• On multiple prescription medicines, berberine affects drug metabolism
• For a child

The short version

1. “Giloy” can mean stem, leaf, or a different species.
2. The species question comes first.
3. Tinospora crispa is a confusable relative with documented hepatotoxicity.
4. Some of the Indian liver case reports may have involved misidentified material, an argument that cuts both ways.
5. Either way, identity testing becomes essential, the practical response is the same.
6. T. cordifolia: smooth heart-shaped leaves, warty stem, thread-like aerial roots.
7. T. crispa: notably more warty and ridged stem, hence the name.
8. In dried or powdered form, visual identification is unreliable, which is how most material trades.
9. Ask how identity was established: macroscopic, microscopic, HPTLC, or DNA barcoding.
10. DNA barcoding is the most definitive for species.
11. A supplier who cannot say how they know is the risk.
12. Classical texts use the stem, and mature stem specifically.
13. Guduchi satva is made from the stem, it is starch-rich, and the leaf is not.
14. Stem and leaf differ in alkaloid, polysaccharide and glycoside profile.
15. They are different chemical mixtures, not the same thing at two prices.
16. Comparative stem-versus-leaf activity research is limited, we will not claim one is clinically better.
17. What we can say: the classical preparations and most research used stem.
18. Leaf is cheaper, more abundant and faster to collect.
19. “Whole plant” or “aerial parts” usually means stem plus leaf in unstated proportion.
20. Leaf products are rarely labelled as leaf, that is the gap to close by asking.
21. Specify stem explicitly, not “whole plant” and not silence.
22. Ask for a marker assay, “giloy extract” with no figure is a commodity.
23. Batch-wise heavy metals, it is a climbing vine and takes up its environment.
24. The neem-host preference is traditional with no modern evidence, a premium for it buys tradition.
25. The 2020–21 demand spike was also the period of maximum supply-chain pressure, the two facts are related.
26. Cultivated material offers traceability as well as conservation.
27. There is no authorised health claim for giloy, whatever the plant part.
28. Stating plant part and identity method on the label is the only thing that makes the quality difference visible.

Ingredient detail: giloy. Composition: giloy juice and giloy capsule. Related: the amrita reputation and the liver question, giloy juice, drops ya tablet, and choosing a contract manufacturer.